Mass Drug Administration (MDA) Campaign to Eliminate Lymphatic Filariasis (LF) &Coverage Evaluation Survey of Katihar District, Bihar
- 1. Assistant Professor and Head, Department of Community Medicine, Government Medical College, Purnea, Bihar
- 2. Tutor, Department of Community Medicine, Government Medical College, Purnea, Bihar
Description
Background: Lymphatic filariasis is targeted for elimination in India through mass drug administration (MDA) with Diiethylcarbamazine (DEC), Albendazole (ABZ) and Ivermectin. MDA were done in Katihar district as well by government. MDA campaign was conducted in February 2024 in Katihar district. Post MDA, a survey was conducted: (i) To estimate the coverage, effective coverage, and compliance of MDA in study area. (ii) To estimate the reasons for non- offering and non-consumption of MDA. Methods: A training session conducted to conduct survey. Survey was done in 5 blocks having 4 villages in each block. Altogether 600 households were surveyed which caters sample size of 2707.Block were selected by lottery methods. Systematic random sampling methods were adopted for the selection of 30 households in each village/urban area. Pretested questionnaire were given to volunteers to collect data. After collecting data it were analyzed. Results: After analyzing the data it was found that percentage of people received Albendazole were 76.1%. And DEC were received by 75.8%. It was also found that 7.5% people have not received even single dose till date even after multiple round of MDA conducted by government. Even after providing MDA some people did not consume the drug. Those who did not consumed Albendazole and DEC were 2.8% & 2.6% respectively. Reason for not consuming the drug were fear of side effects and bad taste mainly. Conclusion: Currently MDA is restricted to the distribution of drugs only and the key issues of implementation in compliance, health education, managing side effects, and logistics are not given enough attention. It is therefore essential to address the issues linked to low compliance to make the program more efficient and achieve the goal of filariasis elimination.
Abstract (English)
Background: Lymphatic filariasis is targeted for elimination in India through mass drug administration (MDA) with Diiethylcarbamazine (DEC), Albendazole (ABZ) and Ivermectin. MDA were done in Katihar district as well by government. MDA campaign was conducted in February 2024 in Katihar district. Post MDA, a survey was conducted: (i) To estimate the coverage, effective coverage, and compliance of MDA in study area. (ii) To estimate the reasons for non- offering and non-consumption of MDA. Methods: A training session conducted to conduct survey. Survey was done in 5 blocks having 4 villages in each block. Altogether 600 households were surveyed which caters sample size of 2707.Block were selected by lottery methods. Systematic random sampling methods were adopted for the selection of 30 households in each village/urban area. Pretested questionnaire were given to volunteers to collect data. After collecting data it were analyzed. Results: After analyzing the data it was found that percentage of people received Albendazole were 76.1%. And DEC were received by 75.8%. It was also found that 7.5% people have not received even single dose till date even after multiple round of MDA conducted by government. Even after providing MDA some people did not consume the drug. Those who did not consumed Albendazole and DEC were 2.8% & 2.6% respectively. Reason for not consuming the drug were fear of side effects and bad taste mainly. Conclusion: Currently MDA is restricted to the distribution of drugs only and the key issues of implementation in compliance, health education, managing side effects, and logistics are not given enough attention. It is therefore essential to address the issues linked to low compliance to make the program more efficient and achieve the goal of filariasis elimination.
Files
IJPCR,Vol16,Issue8,Article78.pdf
Files
(439.8 kB)
| Name | Size | Download all |
|---|---|---|
|
md5:00ebfdcf9351b4f8351b67949fc87037
|
439.8 kB | Preview Download |
Additional details
Dates
- Accepted
-
2024-07-26
Software
- Repository URL
- https://impactfactor.org/PDF/IJPCR/16/IJPCR,Vol16,Issue8,Article78.pdf
- Development Status
- Active
References
- 1. Mass drug administration for lymphatic filariasis elimination in a coastal state of India: a study on barriers to coverage and compliance, Mohammad A Hussain, Ashok K Sitha, Subhashisa Swain, Shridhar Kadam,3 and Sanghamitra Pati, Infect Dis Poverty. 2014; 3: 31, Published online 2014 Sep 1. doi: 10.1186/2049-9957-3-31, PMCID: PMC416 6397 PMID: 25237478 2. A programme to eliminate lymphatic filariasis in Tamil Nadu state, India: compliance with annual single-dose DEC mass treatment and some related operational aspects K D Ramaiah 1, P K Das, N C Appavoo, K Ramu, D J Au-gustin, K N Kumar, A V Chandrakala 2000 Dec;5(12):842-7., PMID: 11169272DOI: 10.1046/j.1365-3156.2000.00659.x 3. Mass Drug Administration (MDA) for Lymphatic Filariasis Elimination in Uttar Pradesh: Lessons Learnt S Kamal1 et al. 1 National Centre for Disease Control (NCDC), Patna, Bihar, India. 2,3,4,5 Regional Office of Health & Family Welfare (NCVBDC), Kendriya Bhawan, Aliganj, Lucknow, Uttar Pardesh, India. 6 District Vector, Borne Disease Control Officer, Lucknow, Uttar Pardesh, India. Journal of Communicable Dis-eases XIV Annual Conference of Indian Society for Malaria & Other Communicable Diseases (ISMOCD) Pg. No. 60-70 DOI: https://doi.org/10.24321/0019. 5138.202338 4. Progress Report 2000–2009 and Strategic Plan 2010–2020 of the Global Program to Eliminate Lym-phatic Filariasis: Halfway Towards Eliminating Lymphatic Filariasis. France: World Health Organization, Ge-neva; 2011 [http:// whqlibdoc.who.int/publications/2010/9789241 500722_eng.pdf] 5. https://katihar.nic.in/ Katihar District Official Website/ About District.